Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity

Background: Obesity is now a common risk factor for non-alcoholic fatty liver disease (NAFLD). Thus, it is important to explore its underlying mechanisms. Methods: Total RNA was extracted from peripheral whole blood samples from 50 NAFLD patients and 50 healthy controls. In addition, human liver spe...

Full description

Bibliographic Details
Main Authors: Lei Wang, Ning Zhang, Zun Wang, Dong-mei Ai, Zhen-yu Cao, Hua-ping Pan
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2016-11-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/447917
_version_ 1818312283869151232
author Lei Wang
Ning Zhang
Zun Wang
Dong-mei Ai
Zhen-yu Cao
Hua-ping Pan
author_facet Lei Wang
Ning Zhang
Zun Wang
Dong-mei Ai
Zhen-yu Cao
Hua-ping Pan
author_sort Lei Wang
collection DOAJ
description Background: Obesity is now a common risk factor for non-alcoholic fatty liver disease (NAFLD). Thus, it is important to explore its underlying mechanisms. Methods: Total RNA was extracted from peripheral whole blood samples from 50 NAFLD patients and 50 healthy controls. In addition, human liver specimens were obtained through liver biopsies from NAFLD patients and healthy controls. The level of miRNA was studied using real-time PCR. The expression of lipogenic genes was analyzed using western blot, and a dual luciferase reporter assay was conducted to identify the possible target gene. Adenovirus vectors were injected into the tail vein of the high fat diet (HFD)-fed mice to study the role of miR-155 on lipid accumulation in vivo. Results: The level of miR-155 was markedly reduced in the livers and peripheral blood of NAFLD patients compared with healthy controls. Upregulation of miR-155 decreased intracellular lipid content and the SREBP1 and FAS protein levels, while inhibition of miR-155 enhanced the intracellular lipid content. The dual luciferase reporter assay showed that Liver X receptor (LXR)α was the target gene of miR-155, and silencing miR-155 reduced the expression of SREBP1 and FAS. An in vivo study showed that upregulation of miR-155 decreased the hepatic lipid accumulation mainly by suppressing the LXRα-dependent lipogenic signaling pathway. Conclusions: In summary, decreased expression of miR-155 in the peripheral blood may be utilized as a potential novel biomarker for NAFLD screening mainly by targeting LXRα.
first_indexed 2024-12-13T08:15:24Z
format Article
id doaj.art-bbb27faeb55a4e4eac7729a663fd8bcd
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-13T08:15:24Z
publishDate 2016-11-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-bbb27faeb55a4e4eac7729a663fd8bcd2022-12-21T23:54:07ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782016-11-013962239224810.1159/000447917447917Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR ActivityLei WangNing ZhangZun WangDong-mei AiZhen-yu CaoHua-ping PanBackground: Obesity is now a common risk factor for non-alcoholic fatty liver disease (NAFLD). Thus, it is important to explore its underlying mechanisms. Methods: Total RNA was extracted from peripheral whole blood samples from 50 NAFLD patients and 50 healthy controls. In addition, human liver specimens were obtained through liver biopsies from NAFLD patients and healthy controls. The level of miRNA was studied using real-time PCR. The expression of lipogenic genes was analyzed using western blot, and a dual luciferase reporter assay was conducted to identify the possible target gene. Adenovirus vectors were injected into the tail vein of the high fat diet (HFD)-fed mice to study the role of miR-155 on lipid accumulation in vivo. Results: The level of miR-155 was markedly reduced in the livers and peripheral blood of NAFLD patients compared with healthy controls. Upregulation of miR-155 decreased intracellular lipid content and the SREBP1 and FAS protein levels, while inhibition of miR-155 enhanced the intracellular lipid content. The dual luciferase reporter assay showed that Liver X receptor (LXR)α was the target gene of miR-155, and silencing miR-155 reduced the expression of SREBP1 and FAS. An in vivo study showed that upregulation of miR-155 decreased the hepatic lipid accumulation mainly by suppressing the LXRα-dependent lipogenic signaling pathway. Conclusions: In summary, decreased expression of miR-155 in the peripheral blood may be utilized as a potential novel biomarker for NAFLD screening mainly by targeting LXRα.http://www.karger.com/Article/FullText/447917miR-155LXRαNAFLDPeripheral blood
spellingShingle Lei Wang
Ning Zhang
Zun Wang
Dong-mei Ai
Zhen-yu Cao
Hua-ping Pan
Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity
Cellular Physiology and Biochemistry
miR-155
LXRα
NAFLD
Peripheral blood
title Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity
title_full Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity
title_fullStr Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity
title_full_unstemmed Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity
title_short Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity
title_sort decreased mir 155 level in the peripheral blood of non alcoholic fatty liver disease patients may serve as a biomarker and may influence lxr activity
topic miR-155
LXRα
NAFLD
Peripheral blood
url http://www.karger.com/Article/FullText/447917
work_keys_str_mv AT leiwang decreasedmir155levelintheperipheralbloodofnonalcoholicfattyliverdiseasepatientsmayserveasabiomarkerandmayinfluencelxractivity
AT ningzhang decreasedmir155levelintheperipheralbloodofnonalcoholicfattyliverdiseasepatientsmayserveasabiomarkerandmayinfluencelxractivity
AT zunwang decreasedmir155levelintheperipheralbloodofnonalcoholicfattyliverdiseasepatientsmayserveasabiomarkerandmayinfluencelxractivity
AT dongmeiai decreasedmir155levelintheperipheralbloodofnonalcoholicfattyliverdiseasepatientsmayserveasabiomarkerandmayinfluencelxractivity
AT zhenyucao decreasedmir155levelintheperipheralbloodofnonalcoholicfattyliverdiseasepatientsmayserveasabiomarkerandmayinfluencelxractivity
AT huapingpan decreasedmir155levelintheperipheralbloodofnonalcoholicfattyliverdiseasepatientsmayserveasabiomarkerandmayinfluencelxractivity